<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A01FD660-9141-46EE-9FFB-9236CE7FBFB4"><gtr:id>A01FD660-9141-46EE-9FFB-9236CE7FBFB4</gtr:id><gtr:name>University of Colorado (Denver)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Inst of Infections and Immunity</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A01FD660-9141-46EE-9FFB-9236CE7FBFB4"><gtr:id>A01FD660-9141-46EE-9FFB-9236CE7FBFB4</gtr:id><gtr:name>University of Colorado (Denver)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5486FFD2-804B-45DB-8EA9-38A8AE0ACD78"><gtr:id>5486FFD2-804B-45DB-8EA9-38A8AE0ACD78</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:surname>Meersmann</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0900785"><gtr:id>48AA0943-59B9-491F-A272-BF4E71FA09C8</gtr:id><gtr:title>Pump-priming capacity development for translational medical research</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900785</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2012-07-15</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-07-16</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1150001</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical School; University of Colorado (Denver)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Development of krypton-83 MRI</gtr:description><gtr:id>653C1F41-4528-4DEC-AEAB-4B611ADB5E47</gtr:id><gtr:impact>The following publications are based on this collaboration:
Zackary I. Cleveland, Karl F. Stupic, Galina E. Pavlovskaya, John E. Repine, Jan B. Wooten, and Thomas Meersmann*, &amp;quot;Hyperpolarized 83Kr and 129Xe NMR Relaxation Measurements of Hydrated Surfaces: Implications for Materials Science and Pulmonary Diagnostics&amp;quot; J. Am. Chem. Soc. 129, (2007), 1784-1792.

Zackary I. Cleveland, Galina E. Pavlovskaya, Karl F. Stupic, Jan B. Wooten, John E. Repine, and Thomas Meersmann*, &amp;quot;Detection of Tobacco Smoke Deposition by Hyperpolarized Krypton-83 MRI.&amp;quot; Magnetic Resonance Imaging, 26, (2008), 270-278.

Zackary I. Cleveland, Galina E. Pavlovskaya, Karl F. Stupic, Nancy D. Elkins, John E. Repine, and Thomas Meersmann*, &amp;quot;In Situ Hyperpolarized 83Kr MRI of Lungs&amp;quot; Journal of Magnetic Resonance 195, (2008), 232-237.

Karl F. Stupic, Nancy D. Elkins, Galina E. Pavlovskaya, John E. Repine and T. Meersmann, &amp;quot;Effects of Pulmonary Inflation on Hyperpolarized Krypton-83 Magnetic Resonance T1 Relaxation.&amp;quot;, Physics in Medicine and Biology, 56 (2011) 3731-3748.</gtr:impact><gtr:partnerContribution>provided excised rat lungs of healthy animals or animal with acute lung injury</gtr:partnerContribution><gtr:piContribution>Developed 83Kr MRI using excised rat lungs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemical and Environmental Engineering</gtr:department><gtr:description>Hyperpolarized noble gas MRI contrast agents through catalytic hydrogen combustion</gtr:description><gtr:id>E273A6D3-41B0-4B32-BE4B-7278BB2F4476</gtr:id><gtr:impact>The collaboration has resulted in in a paper, accepted in the Proceedings of the National Academy of Sciences of the USA (PNAS) entiteled:
Molecular hydrogen and catalytic combustion in the production of hyperpolarized 83Kr and 129Xe MRI contrast agents.
We are currently applying for funding to move this project beyond the proof of principle stage. `</gtr:impact><gtr:partnerContribution>There are a number of chemical engineering related problems that need expert input, for example how to best remove the buffer gas. The collaborator have helped with the planning of the project. Furthermore, I co-supervising a student with the collaborators and this student has participated in the project. Further input is required to move this project beyond the proof of concept stage and the collaborations are therefore continuing.</gtr:partnerContribution><gtr:piContribution>My group has utilized catalytic hydrogen combustion, a process that is typically associated with clean energy related sciences, for the production of inhalable contrast agents for magnetic resonance imaging (MRI). The proof-of-concept work, now published in the Proceedings of the National Academy of Sciences, produced purified laser-pumped krypton gas that may serve as a promising new contrast agent for pulmonary MRI. Pulmonary MRI with laser-pumped krypton had previously been demonstrated conceptually but its application had been hampered by limitations in the production process of this contrast agent.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biomedical Sciences Nottingham</gtr:department><gtr:description>Refining Modles of Fibrotic Lung Disease</gtr:description><gtr:id>2FF7DD2D-0332-48C9-9999-E6C871A48822</gtr:id><gtr:impact>NC3R Funding obtained (Co-I) PI Dr. Gisli Jenkins</gtr:impact><gtr:partnerContribution>Help in development of excised lung for MRI applications</gtr:partnerContribution><gtr:piContribution>Provided preliminary ventilation Lung MRI for animal model of disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>COST LEiden</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F89F77B3-F0C1-424C-8081-4C9A9C40A451</gtr:id><gtr:impact>presented 'Polarization transfer in SEOP for spin I = &amp;frac12; noble gas isotopes'

COST workshop: 'Hot Topics in Spin Hyperpolarization', Lorentz Centre, Leiden,</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.lorentzcenter.nl/lc/web/2012/477/info.php3?wsid=477</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>COST</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>93A5CE3A-899D-43FC-8FDA-3F2C9EEDFBDA</gtr:id><gtr:impact>presented: 'New methods and recent advances in hp 83Kr and hp 129Xe MRI'

Student exchange with German research group (University of Leibzig)</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.cost.eu/domains_actions/mpns/Actions/TD1103</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>82000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Confidence in Concepts.</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:id>3A4F5240-B160-4BC2-AA2F-8E60226BA25A</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Paul Instrument Fund</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>F83FA36D-35BB-45B5-9E5D-CDDCA643FFE6</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>BBSRC Impact Award</gtr:department><gtr:description>BBSRC Pathway to Impact</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/N021460/1</gtr:fundingRef><gtr:id>D525F732-EAB6-4C32-8C22-4E797A43A441</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Discovery Award</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:fundingRef>MP_PCP15074</gtr:fundingRef><gtr:id>BADF3209-D69D-4FBA-A4F6-9C1EE374699C</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development of cryogen-free 129Xe and 83Kr hyperpolarizer to enable and facilitate pre-clinical MRI of lungs'</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:fundingRef>Paul Instrument Fund</gtr:fundingRef><gtr:id>4BCB2AD4-2D3D-4745-BD9F-9AA6341A184C</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:fundingRef>G1100564</gtr:fundingRef><gtr:id>3A2BEDA9-4BC4-4772-9893-09139679AC30</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>553341</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:fundingRef>G1100564</gtr:fundingRef><gtr:id>D8F60737-F31D-411D-B223-2CA2C7C300C2</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>In order to allow for an expedite research activities at the Nottingham Translational Imaging Center, the following infrastructural work was accomplished: 
1.) Instruments and devises for the production of hyperpolarized gases have been developed and assembled. The technology is based on previous research at Colorado State University (CSU) and on recent developments in Nottingham. Almost the complete previous laboratory was relocated (free of charge except transportation) from Colorado to the University of Nottingham. Major items include: a.) one already assembled hyperpolarization devise and parts for a partially assembled second system, b.) a gas delivery system including vacuum unit, gas mixing, peristaltic pumps, high purity filtration. c.) a 9.4 T superconducting magnet (89 mm vertical bore) for micro imaging and NMR spectroscopy d.) A microimaging gradient system including amplifiers and gradient coils. e.) 0 - 3 T superconducting magnet (89 mm vertical bore) for field cycling (i.e. field dependent noble gas relaxation measurements), including charging system to allow for the field ramping. f.) Various glassware specifically designed for the experiments. g.) Various NMR/MRI probe heads for work with hyperpolarized noble gases. 
The the laboratory equipment from Colorado was moved to the UK, temporarily stored, refitted where needed (different electrical, and gas delivery requirement, different usage compared to previous) and further assembled. New develpments have been made in improving the hyperpolarization of the MRI contrast agents. 

2.) Acquisition of new equipment. The following major items have been purchased: a.) a state-of-the-art 9.4T Microimaging system from Bruker with 'ultrashielded' magnet . This system will be a primary research instrumentation in the translational imaging laboratory. It will also allow for flow (blood flow) measurements in model systems and for rheological NMR experiments. The system includes a variety of radio frequency coils for detection. The system is currently been tested and a number of items have been returned for modification b.) A low cost console for the second 9.4 T MRI system and existing microimaging system (both transfers from Colorado). The magnet has been energized to 9.4 T initially but can be ramped to any field below this value if needed. The system will also allow for optical pumping in the stray-field of the unshielded magnet. c.) A Rheo-meter to complement the Bruker Rheological NMR system (still in purchasing the processes). 

3.) Development and construction of MRI Coils for hyperpolarized xenon-129 and krypton-83 for 7.4 T small animal imaging system at the University of Nottingham Brain and Body Centre and for 3 T whole body Philips MRI system (still in process). 

4.) Hiring of personnel: one post-graduate student has joined in January 2010 and a second post graduate student has joined in September 2010. A post doctoral researcher has joined in April 2010. A lecturer has joined University of Nottingham who will be crucial for the Rheological and blood flow work. A further post graduate student (with medical doctorate degee) has joined the group in April 2011. 

5.) Planning of major reconstruction of Lab space at the Sir Peter Mansfield Magnetic Resonance Centre to accommodate the vertical bore microimaging systems. Although the actual construction is not part of this grant, planning from the on-set because this work is crucial from the infrastructure point of view. Because of too low ceiling height at the centre major reconstruction within the existing building was necessary. The planning allowed for significant extra laboratory space within the existing building. Work was completed in early April 2010.

6.) A new hyperpolarizer system has been successfully developed in 2011 that allows for the production of hp xenon-129 and krypton-83 without cryogenic separation. A publication is currently pending and the system is in used of work with excised lungs where it has produced first pulmonary MR images of excised rodent lungs. A second system is currently been revised to produce larger quantities of hp gas for pulmonary MRI.

7.) Transverse relaxation measurements of hp xenon-129 and krypton-83 have produced new insights in the relaxation behavior of the gases in confined porous models systems and lungs. The work is currently ongoing.</gtr:description><gtr:id>DC2D441C-55A3-494E-94C3-BDD92142AC69</gtr:id><gtr:impact>Using the hyperpolarizer system described in 6.) lung studies have been initiated in animal models of pulmonary disease. This work is performed in collaboration with researchers at the respiratory biomedical research unit in Nottingham. First results have been obtained (see other out puts and knowledge section). 
Added in 2016: The instrument has made a number of breakthrough developments possible. In particular it has enabled us do provide the first demonstration of hyperpolarized krypton as a novel pulmonary MRI contrast agent that is sensitive to an animal model of emphysema.
Building on this development, hyperpolarized 83Kr MRI will now be implemented at Nottingham's 7T whole body MRI to prepare for a future phase 1 trail. The necessary 7T upgrade was supported as part of the MRC funded 'Enhancing UK's clinical research infrastructure' awarded to Nottingham in 2015.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Build up of MRI methodology development laboratory for translational imaging research.</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>A new addition to the laser-pumped noble gas MRI contrast agent family is krypton-83. My team in Nottingham has demonstrated the sensitivity of this contrast agent for emphysema (model) related changes in the lung surface. However, this distinct sensitivity also leads to complications in the production of this novel contrast agent for clinical applications. The success of the laser pumping process is measured by the enhancement factor in the MRI sensitivity that is many orders of magnitude above the pre-pumped state. In order to reach this enhancement, xenon-129 or krypton-83 are usually diluted by other gases during laser pumping. For MRI usage, these additional gases are usually removed after the pumping process. However, the gas removal from laser pumped krypton-83 mixture was previously not possible because conventional &amp;quot;cleaning up&amp;quot; methods lead to the complete loss of the hyperpolarized state, rendering the contrast agent useless for MRI. 
We have now solved this problem by diluting krypton-83 in molecular hydrogen gas (H2) for the laser pumping process. After successful laser pumping, the hydrogen gas is removed in a safe and controlled fashion through a catalysed combustion reaction. Water vapour, the sole product of the 'clean' hydrogen reaction, is easily removed through condensation, leaving behind the purified laser-polarized krypton-83 gas diluted only by small remaining quantities of harmless water vapour. This development significantly improves the potential usefulness of laser-pumped krypton-83 as MRI contrast agent for clinical applications. The novel methodology can also be utilized for laser polarized xenon-129 and may lead to a cheaper and more accessible production of this contrast agent.</gtr:description><gtr:id>161F467F-E1C4-4E3E-B15A-53E375E6C584</gtr:id><gtr:impact>Has just been completed - no output yet.</gtr:impact><gtr:title>New production method for hyperpolarized noble gas contrast agents</gtr:title><gtr:type>New/Improved Technique/Technology</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/465BA56C-7D1C-420B-8295-A613E3D02C07"><gtr:id>465BA56C-7D1C-420B-8295-A613E3D02C07</gtr:id><gtr:title>Molecular Sensing with Hyperpolarized (129) Xe Using Switchable Chemical Exchange Relaxation Transfer.</gtr:title><gtr:parentPublicationTitle>Chemphyschem : a European journal of chemical physics and physical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ce49bf9e5b0cab623f8c03a565e1a86"><gtr:id>8ce49bf9e5b0cab623f8c03a565e1a86</gtr:id><gtr:otherNames>Zamberlan F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1439-4235</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E95E508B-2224-41D0-A6CA-752E7FFA4D8B"><gtr:id>E95E508B-2224-41D0-A6CA-752E7FFA4D8B</gtr:id><gtr:title>Perspectives of hyperpolarized noble gas MRI beyond 3He.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance (San Diego, Calif. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b747b4ebf6ba8a2bbf940b1cf382e4b5"><gtr:id>b747b4ebf6ba8a2bbf940b1cf382e4b5</gtr:id><gtr:otherNames>Lilburn DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1090-7807</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/716D8740-F13B-470F-A1E5-1BCD9515E109"><gtr:id>716D8740-F13B-470F-A1E5-1BCD9515E109</gtr:id><gtr:title>Hyperpolarized 83Kr magnetic resonance imaging of alveolar degradation in a rat model of emphysema.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b747b4ebf6ba8a2bbf940b1cf382e4b5"><gtr:id>b747b4ebf6ba8a2bbf940b1cf382e4b5</gtr:id><gtr:otherNames>Lilburn DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/825258C6-DF56-4B7E-B661-661DCADBB264"><gtr:id>825258C6-DF56-4B7E-B661-661DCADBB264</gtr:id><gtr:title>Pathway to cryogen free production of hyperpolarized Krypton-83 and Xenon-129.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/79a6b5c33403d2572c67f22d6c58e3f4"><gtr:id>79a6b5c33403d2572c67f22d6c58e3f4</gtr:id><gtr:otherNames>Six JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A38E5E7A-CDAC-4184-9C4B-B92C2A50D5A5"><gtr:id>A38E5E7A-CDAC-4184-9C4B-B92C2A50D5A5</gtr:id><gtr:title>Pulmonary MRI contrast using Surface Quadrupolar Relaxation (SQUARE) of hyperpolarized (83)Kr.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/79a6b5c33403d2572c67f22d6c58e3f4"><gtr:id>79a6b5c33403d2572c67f22d6c58e3f4</gtr:id><gtr:otherNames>Six JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0730-725X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CD81AA45-1F73-4316-9D7B-5879DCE006FB"><gtr:id>CD81AA45-1F73-4316-9D7B-5879DCE006FB</gtr:id><gtr:title>Spatial Mapping of Flow-Induced Molecular Alignment in a Noncrystalline Biopolymer Fluid Using Double Quantum Filtered (DQF) (23)Na MRI.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/21fa4c604ebdb5fb8093dedbaf1825d0"><gtr:id>21fa4c604ebdb5fb8093dedbaf1825d0</gtr:id><gtr:otherNames>Pavlovskaya GE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1948-7185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E78CF66-1637-4605-9CF5-7CE42701D571"><gtr:id>0E78CF66-1637-4605-9CF5-7CE42701D571</gtr:id><gtr:title>Validating excised rodent lungs for functional hyperpolarized xenon-129 MRI.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b747b4ebf6ba8a2bbf940b1cf382e4b5"><gtr:id>b747b4ebf6ba8a2bbf940b1cf382e4b5</gtr:id><gtr:otherNames>Lilburn DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1DE72BE-B2D3-4B02-9DED-4AAAB1D79000"><gtr:id>A1DE72BE-B2D3-4B02-9DED-4AAAB1D79000</gtr:id><gtr:title>Molecular hydrogen and catalytic combustion in the production of hyperpolarized 83Kr and 129Xe MRI contrast agents.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/82d81e602a600f613a2ccc3d8efa8905"><gtr:id>82d81e602a600f613a2ccc3d8efa8905</gtr:id><gtr:otherNames>Rogers NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1EE20B8E-5940-4751-A943-B79224A8EEBE"><gtr:id>1EE20B8E-5940-4751-A943-B79224A8EEBE</gtr:id><gtr:title>Cryogenics free production of hyperpolarized 129Xe and 83Kr for biomedical MRI applications.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance (San Diego, Calif. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02bcd00ef63ea8f701a0aee478bbb624"><gtr:id>02bcd00ef63ea8f701a0aee478bbb624</gtr:id><gtr:otherNames>Hughes-Riley T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1090-7807</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/917E3CF4-1F0E-4CC4-BDF0-D5B078510BF5"><gtr:id>917E3CF4-1F0E-4CC4-BDF0-D5B078510BF5</gtr:id><gtr:title>Combustion resistance of the 129Xe hyperpolarized nuclear spin state.</gtr:title><gtr:parentPublicationTitle>Physical chemistry chemical physics : PCCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f8851f233ac64c819094688cad7b5e2"><gtr:id>3f8851f233ac64c819094688cad7b5e2</gtr:id><gtr:otherNames>Stupic KF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1463-9076</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4E0F412D-DC03-4191-B499-90CEF20FBAB5"><gtr:id>4E0F412D-DC03-4191-B499-90CEF20FBAB5</gtr:id><gtr:title>Hyperpolarized (131)Xe NMR spectroscopy.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance (San Diego, Calif. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f8851f233ac64c819094688cad7b5e2"><gtr:id>3f8851f233ac64c819094688cad7b5e2</gtr:id><gtr:otherNames>Stupic KF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1090-7807</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/366D49CC-8BD4-45A9-A78E-6275029FA544"><gtr:id>366D49CC-8BD4-45A9-A78E-6275029FA544</gtr:id><gtr:title>Effects of pulmonary inhalation on hyperpolarized krypton-83 magnetic resonance T1 relaxation.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f8851f233ac64c819094688cad7b5e2"><gtr:id>3f8851f233ac64c819094688cad7b5e2</gtr:id><gtr:otherNames>Stupic KF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5499544B-1FAB-44C4-9A1C-4F4A75E6BDD8"><gtr:id>5499544B-1FAB-44C4-9A1C-4F4A75E6BDD8</gtr:id><gtr:title>Investigating lung responses with functional hyperpolarized xenon-129 MRI in an ex vivo rat model of asthma.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b747b4ebf6ba8a2bbf940b1cf382e4b5"><gtr:id>b747b4ebf6ba8a2bbf940b1cf382e4b5</gtr:id><gtr:otherNames>Lilburn DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900785</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>